Modelling the optimal radiotherapy regime for the control of T2 laryngeal carcinoma using parameters derived from several datasets

This publication has 33 references indexed in Scilit:

• 107A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinomas of the larynx and pharynx
  Radiotherapy and Oncology, 1996
• 106An overview of the EORTC accelerated and hyperfractionated radiotherapy trials in head & neck cancers
  Radiotherapy and Oncology, 1996
• Radiobiological considerations in the design of clinical trials
  Radiotherapy and Oncology, 1994
• Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada
  Radiotherapy and Oncology, 1994
• Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues
  Radiotherapy and Oncology, 1992
• Steepness of the Clinical Dose–control Curve and Variation in thein VitroRadiosensitivity of Head and Neck Squamous Cell Carcinoma
  International Journal of Radiation Biology, 1992
• Clinical evidence for tumor clonogen regeneration: interpretations of the data
  Radiotherapy and Oncology, 1991
• Fast neutron treatment for squamous cell carcinoma of the head and neck: final report of Edinburgh randomised trial.
  BMJ, 1990
• T2 Glottic Cancer: Recurrence, Salvage, and Survival After Definitive Radiotherapy
  JAMA Otolaryngology–Head & Neck Surgery, 1990
• Prognostic factors in T2 glottic cancer
  Cancer, 1980